CancerTYPE ID in the Clinic

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
March 31, 2015

Reality of the ASPIRE Study

Ajai Chari, MD, at the Mount Sinai School of Medicine in New York, deliberates on the results of the ASPIRE study as the most important thing to come out of ASH for the myeloma community. He mentions that although the study has very positive indications, the therapy isn’t really appropriate [ Read More ]

July 29, 2015

Making Cancer Care More Cost-Effective

Dr. Alex Adjei offers options to make cancer care more cost-effective, such as selecting only patients who will benefit from treatment and continuing to offer treatments that will allow patients to remain in the workforce.